Clinical Study Results
What serious adverse reactions happened during this study?
None of the participants who got MEDI3902 had serious adverse reactions during
this study.
There were 1.2% of participants who got the placebo who had serious adverse
reactions during this study. This was 1 out of 83 participants. This participant had
the serious adverse reaction of kidney injury.
None of the participants died due to serious adverse reactions during this study.
What adverse reactions happened during this study?
The most common adverse reaction that happened during this study was skin
reaction at the infusion site. The adverse reactions that happened in this study
were:
• A skin reaction at the site of the infusion happened in 2.4% of participants who got
1,500 mg of MEDI3902. This was 2 out of 85 participants.
• Increased heart rate happened in 1.2% of participants who got 1,500 mg of
MEDI3902. This was 1 out of 85 participants.
• A kidney injury happened in 1.2% of participants who got the placebo. This was 1 out
of 83 participants.
How has this study helped patients and
researchers?
This study helped researchers learn about using MEDI3902 in people who are on
breathing machines and are at risk of developing bacterial pneumonia.
Researchers look at the results of many studies to decide which treatments work
best and are safest. This summary shows only the main results from this one study.
Other studies may provide new information or different results.
Further clinical studies with MEDI3902 are not planned.
11